From Acute Altered States to Durable Change: A Social-Psychological Framework for Contextual Framing, Integration, and Post-Acute Stabilization

Recent psychedelic research has shown that compounds such as psilocybin, DMT, ayahuasca, and 5-MeO-DMT can induce acute altered states involving self-dissolution, altered reality-status, and heightened meaning attribution. Historical and cross-cultural evidence likewise suggests that nonordinary states have often been embedded within ritual, initiation, contemplative discipline, and structured interpretive systems rather than treated as isolated pharmacological events. This article develops a theoretical framework for understanding how acute altered states may, or may not, become durable psychological, behavioral, and existential change. It argues that acute intensity alone is insufficient and that contextual framing, post-acute integration, and pre-existing integrative capacities jointly shape long-term outcomes. The framework compares DMT, ayahuasca, 5-MeO-DMT, psilocybin, LSD/lysergamides, contemplative practice, fasting, breathwork, and near-death experiences without claiming causal identity among them. It concludes with testable hypotheses concerning contextual framing, recall, integration, individual differences, and durable transformation.

psychedelics; altered states; contextual framing; integration

1. [1] Antonopoulos, R. K., et al. (2026). Investigating the psychedelic hypothesis of kykeon, the sacred elixir of the Eleusinian Mysteries. Scientific Reports, 16, 8757. https://doi.org/10.1038/s41598-026-39568-3 [Google Scholar] [Crossref]

2. [2] Barba, T., et al. (2024). The potential of 5-methoxy-N,N-dimethyltryptamine in mental health treatment. Neuroscience & Biobehavioral Reviews, 161, 105694. https://doi.org/10.1016/j.neubiorev.2024.105694 [Google Scholar] [Crossref]

3. [3] Barker, S. A. (2018). N,N-Dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function. Frontiers in Neuroscience, 12, 536. https://doi.org/10.3389/fnins.2018.00536 [Google Scholar] [Crossref]

4. [4] Dean, J. G., et al. (2019). Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Scientific Reports, 9, 9333. https://doi.org/10.1038/s41598-019-45812-w [Google Scholar] [Crossref]

5. [5] Efthimiou, A. A., et al. (2024). The role of music in psychedelic-assisted therapy: A comparative analysis of neuroscientific research, indigenous entheogenic ritual, and contemporary care models. Psychedelic Medicine, 2(4), 221-233. https://doi.org/10.1089/psymed.2023.0058 [Google Scholar] [Crossref]

6. [6] Griffiths, R. R., et al. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology, 32(1), 49-69. https://doi.org/10.1177/0269881117731279 [Google Scholar] [Crossref]

7. [7] Johnson, M. W., et al. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 142, 143-166. https://doi.org/10.1016/j.neuropharm.2018.05.012 [Google Scholar] [Crossref]

8. [8] Ko, K., et al. (2022). Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Frontiers in Psychiatry, 13, 917199. https://doi.org/10.3389/fpsyt.2022.917199 [Google Scholar] [Crossref]

9. [9] Lawrence, D. W., et al. (2022). Phenomenology and content of the inhaled N,N-dimethyltryptamine (N,N-DMT) experience. Scientific Reports, 12, 8562. https://doi.org/10.1038/s41598-022-11999-8 [Google Scholar] [Crossref]

10. [10] Meling, D., et al. (2024). Meditating on psychedelics: A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat. Journal of Psychopharmacology, 38(10), 897-910. https://doi.org/10.1177/02698811241282637 [Google Scholar] [Crossref]

11. [11] Muthukumaraswamy, S. D., et al. (2025). Psychedelic-assisted therapy as a complex intervention: Implications for clinical trial design. Therapeutic Advances in Psychopharmacology, 15, 20451253251381074. https://doi.org/10.1177/20451253251381074 [Google Scholar] [Crossref]

12. [12] Timmermann, C., et al. (2025). Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. Neuroscience of Consciousness, 2025(1), niaf007. https://doi.org/10.1093/nc/niaf00 [Google Scholar] [Crossref]

• Assessment of the Role of Artificial Intelligence in Repositioning TVET for Economic Development in Nigeria
• Teachers’ Use of Assure Model Instructional Design on Learners’ Problem Solving Efficacy in Secondary Schools in Bungoma County, Kenya
• “E-Booksan Ang Kaalaman”: Development, Validation, and Utilization of Electronic Book in Academic Performance of Grade 9 Students in Social Studies
• Analyzing EFL University Students’ Academic Speaking Skills Through Self-Recorded Video Presentation
• Major Findings of The Study on Total Quality Management in Teachers’ Education Institutions (TEIs) In Assam – An Evaluative Study